Carbidopa And Levodopa Tablet, Orally Disintegrating
Product Images NDC 16571-159

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 16571-159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbidopa Label-1..jpg (Carbidopa Label 1.)

Carbidopa Label-1..jpg (Carbidopa Label 1.)
The text appears to be a description of a medication containing Carbidopa and Levodopa tablets. Each tablet contains 10 mg of Carbidopa and 100 mg of Levodopa. The medication is manufactured by Rising Pharma Holdings, Inc. and is dispensed in a tight, light-resistant container. It is important to store the tablets at 20° to 25°C (68° to 77°F) and protect them from moisture and light. The medication is made in India and contains phenylalanine. It should be kept out of reach of children and only removed from the bottle immediately before use. For specific dosage information, the accompanying prescribing information should be consulted.*
FDA Label Image

Carbidopa Label-2.jpg (Carbidopa Label 2)

Carbidopa Label-2.jpg (Carbidopa Label 2)
This text provides information about Carbidopa and Levodopa Orally Disintegrating Tablets, USP at a strength of 25 mg/100 mg. The tablets contain Carbidopa, USP, and Levodopa, USP. The packaging consists of 100 tablets and each tablet contains phenylalanine. The usual dosage information can be found in the accompanying prescribing information. It advises to store the medication in a light-resistant container at 20° to 25°C (68° to 77°F) and protect it from moisture and light. The tablets should not be removed from the bottle until immediately before use. The manufacturer is Rising Pharma Holdings, Inc., located in East Brunswick, NJ, and the product is made in India.*
FDA Label Image

Carbidopa Label-3..jpg (Carbidopa Label 3.)

Carbidopa Label-3..jpg (Carbidopa Label 3.)
This is a description of a medication in tablet form containing 25mg of Carbidopa and 250mg of Levodopa. It is manufactured by Rising Pharma Holdings, Inc. and is prescribed for oral use. The tablets should be kept in a light-resistant container at a temperature between 20 to 26°C. It contains phenylalanine and should be protected from moisture and light. The medication is child-resistant and should be kept out of the reach of children. Make sure to keep the container tightly closed and only remove tablets right before use.*
FDA Label Image

Carbidopa-structural-formula.jpg (Carbidopa Structural Formula)

FDA Label Image

Levodopa-structural-formula.jpg (Levodopa Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.